Literature DB >> 29179872

Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.

Carine Dochez1, Rosemary J Burnett2, Symplice Mbola Mbassi3, Fred Were4, Andrew Musyoki2, Daisy Trovoada5, M Jeffrey Mphahlele6.   

Abstract

Several African countries have recently introduced or are currently introducing the HPV vaccine, either nationwide or through demonstration projects, while some countries are planning for introduction. A collaborative project was developed to strengthen country adolescent immunisation programmes and health systems in the African Region, addressing unique public health considerations of HPV vaccination: adolescents as the primary target group, delivery platforms (e.g. school-based and facility based), socio-behavioural issues, and the opportunity to deliver other health interventions alongside HPV vaccination. Following a successful "taking-stock" meeting, a training programme was drafted to assist countries to strengthen the integration of adolescent health interventions using HPV vaccination as an entry point. Two workshops were conducted in the Eastern and Southern African Regions. All countries reported on progress made during a final joint symposium. Of the 20 countries invited to participate in either of the workshops and/or final symposium, 17 countries participated: Angola, Botswana, Ethiopia, Kenya, Malawi, Mauritius, Mozambique, Namibia, Rwanda, Seychelles, South Africa, South Sudan, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe. Countries that are currently implementing HPV vaccination programmes, either nationally or through demonstration projects, reported varying degrees of integration with other adolescent health interventions. The most commonly reported adolescent health interventions alongside HPV vaccination include health education (including sexually transmitted infections), deworming and delivering of other vaccines like tetanus toxoid (TT) or tetanus diphtheria (Td). The project has successfully (a) established an African-based network that will advocate for incorporating the HPV vaccine into national immunisation programmes; (b) created a platform for experience exchange and thereby contributed to novel ideas of revitalising and strengthening school-based health programmes as delivery platform of adolescent immunisation services and other adolescent health interventions, as well as identifying ways of reaching out-of-school girls through facility and community based programmes; and (c) laid a foundation for incorporating future adolescent vaccination programmes.
Copyright © 2017.

Entities:  

Keywords:  Adolescent health; Africa; Capacity building; HPV vaccination; New vaccine introduction; School-based vaccination

Mesh:

Substances:

Year:  2017        PMID: 29179872      PMCID: PMC7268102          DOI: 10.1016/j.pvr.2017.08.003

Source DB:  PubMed          Journal:  Papillomavirus Res        ISSN: 2405-8521


  18 in total

Review 1.  Present status of human papillomavirus vaccine development and implementation.

Authors:  Rolando Herrero; Paula González; Lauri E Markowitz
Journal:  Lancet Oncol       Date:  2015-05       Impact factor: 41.316

2.  Achieving high coverage in Rwanda's national human papillomavirus vaccination programme.

Authors:  Agnes Binagwaho; Claire M Wagner; Maurice Gatera; Corine Karema; Cameron T Nutt; Fidele Ngabo
Journal:  Bull World Health Organ       Date:  2012-05-23       Impact factor: 9.408

3.  Using a school-based approach to deliver immunization—global update.

Authors:  Jos Vandelaer; Marianne Olaniran
Journal:  Vaccine       Date:  2014-12-15       Impact factor: 3.641

4.  HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection.

Authors:  Troy J Kemp; Allan Hildesheim; Mahboobeh Safaeian; Joseph G Dauner; Yuanji Pan; Carolina Porras; John T Schiller; Douglas R Lowy; Rolando Herrero; Ligia A Pinto
Journal:  Vaccine       Date:  2011-01-15       Impact factor: 3.641

Review 5.  Immunizing school-age children and adolescents: experience from low- and middle-income countries.

Authors:  Maria Sophia Mackroth; Kathleen Irwin; Jos Vandelaer; Joachim Hombach; Linda O Eckert
Journal:  Vaccine       Date:  2009-12-14       Impact factor: 3.641

Review 6.  Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.

Authors:  Talía Malagón; Mélanie Drolet; Marie-Claude Boily; Eduardo L Franco; Mark Jit; Jacques Brisson; Marc Brisson
Journal:  Lancet Infect Dis       Date:  2012-08-22       Impact factor: 25.071

Review 7.  Effective health interventions for adolescents that could be integrated with human papillomavirus vaccination programs.

Authors:  Nathalie Broutet; Nicholas Lehnertz; Garrett Mehl; Alma Virginia Camacho; Paul Bloem; Venkatraman Chandra-Mouli; Jane Ferguson; Bruce Dick
Journal:  J Adolesc Health       Date:  2013-05-01       Impact factor: 5.012

Review 8.  Global burden of human papillomavirus and related diseases.

Authors:  David Forman; Catherine de Martel; Charles J Lacey; Isabelle Soerjomataram; Joannie Lortet-Tieulent; Laia Bruni; Jerome Vignat; Jacques Ferlay; Freddie Bray; Martyn Plummer; Silvia Franceschi
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

9.  Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland.

Authors:  K G J Pollock; K Kavanagh; A Potts; J Love; K Cuschieri; H Cubie; C Robertson; M Cruickshank; T J Palmer; S Nicoll; M Donaghy
Journal:  Br J Cancer       Date:  2014-09-02       Impact factor: 7.640

10.  Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types.

Authors:  K Kavanagh; K G J Pollock; A Potts; J Love; K Cuschieri; H Cubie; C Robertson; M Donaghy
Journal:  Br J Cancer       Date:  2014-04-15       Impact factor: 7.640

View more
  6 in total

Review 1.  Cervical cancer in Tanzania: A systematic review of current challenges in six domains.

Authors:  Ava S Runge; Megan E Bernstein; Alexa N Lucas; Krishnansu S Tewari
Journal:  Gynecol Oncol Rep       Date:  2019-05-21

Review 2.  Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?

Authors:  Edina Amponsah-Dacosta; Ntombifuthi Blose; Varsetile Varster Nkwinika; Viola Chepkurui
Journal:  Front Public Health       Date:  2022-01-31

3.  Editorial: Advances in adolescent vaccination programs in Low- and Middle-Income Countries (LMICs): A focus on HPV vaccination capacity strengthening.

Authors:  Carine Dochez; Benjamin M Kagina
Journal:  Front Public Health       Date:  2022-07-20

4.  Examining enablers of vaccine hesitancy toward routine childhood and adolescent vaccination in Malawi.

Authors:  Gbadebo Collins Adeyanju; Cornelia Betsch; Abdu A Adamu; Khadijah Sanusi Gumbi; Michael G Head; Aristide Aplogan; Haoua Tall; Tene-Alima Essoh
Journal:  Glob Health Res Policy       Date:  2022-08-18

Review 5.  Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination.

Authors:  Eleanor Black; Robyn Richmond
Journal:  Vaccines (Basel)       Date:  2018-09-08

Review 6.  Stakeholders' Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review.

Authors:  Caroline Deignan; Alison Swartz; Sara Cooper; Christopher J Colvin
Journal:  Vaccines (Basel)       Date:  2021-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.